Intravitreal Bevacizumab Combined With PDT Versus Bevacizumab to Treat Exudative AMD

NCT00684853 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Macular Degeneration

Interventions

DRUG: bevacizumab
DRUG: vetaporfin

Sponsor

Federal University of São Paulo